Experimental: kisspeptin, GnRH
Intravenous (IV) or subcutaneous (SC) administration of kisspeptin 112-121 and/or administration of GnRH
Drug: kisspeptin 112-121
One or more IV or SC doses of kisspeptin 112-121, and/or short infusion (up to 12 hours) of kisspeptin 112-121
Other Name: metastin 45-54
Drug: GnRH
One or more IV doses of GnRH, and/or SC administration of GnRH
Other Name: gonadotropin-releasing hormone
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
